Topical Administration of a Marine Oil Rich in Pro-Resolving Lipid Mediators Accelerates Wound Healing in Diabetic db/db Mice through Angiogenesis and Macrophage Polarization.

Impaired wound healing in patients with type 2 diabetes (DM2) is characterized by chronic inflammation, which delays wound closure. Specialized pro-resolving lipid mediators (SPMs) are bioactive molecules produced from essential polyunsaturated fatty acids (PUFAs), principally omega-3 docosahexaenoi...

Descripción completa

Detalles Bibliográficos
Autores: Ontoria-Oviedo, I, Amaro-Prellezo, E, Castellano, D, Venegas-Venegas, E, Gonzalez-Santos, F, Ruiz-Sauri, A, Pelacho, B, Prosper, F, del Caz, MDP, Sepulveda, P
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:INCLIVA
Repositorio:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
OAI Identifier:oai:incliva.fundanetsuite.com:p16905
Acceso en línea:https://incliva.portalinvestigacion.com/publicaciones/16905
Access Level:acceso abierto
Palabra clave:SPMs
angiogenesis
diabetic ulcer
macrophage polarization
omega-3
pro-resolving lipid mediators
wound healing
Descripción
Sumario:Impaired wound healing in patients with type 2 diabetes (DM2) is characterized by chronic inflammation, which delays wound closure. Specialized pro-resolving lipid mediators (SPMs) are bioactive molecules produced from essential polyunsaturated fatty acids (PUFAs), principally omega-3 docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). SPMs are potent regulators of inflammation and have been used to suppress chronic inflammation in peripheral artery disease, non-alcoholic fatty liver disease, and central nervous system syndromes. LIPINOVA(®) is a commercially available safe-grade nutritional supplement made from a fractionated marine lipid concentrate derived from anchovy and sardine oil that is rich in SPMs and EPA, as well as DHA precursors. Here, we assessed the effect of LIPINOVA(®) in wound dressing applications. LIPINOVA(®) showed biocompatibility with keratinocytes and fibroblasts, reduced the abundance of pro-inflammatory macrophages (Mf1), and promoted in vitro wound closure. Daily application of the marine oil to open wounds made by punch biopsy in db/db mice promoted wound closure by accelerating the resolution of inflammation, inducing neoangiogenesis and Mf1/Mf2 macrophage polarization. In conclusion, LIPINOVA(®) displays pro-resolutive properties and could be exploited as a therapeutic agent for the treatment of diabetic ulcers.